Antibiotic resistance of non-fermenting Gram-negative bacilli in a tertiary hospital in Niger: a prospective cross-sectional study.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 40664412.
- Also identified by DOI 10.1136/bmjopen-2024-092753 and PMC identifier 12265797.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study aimed to determine the prevalence and antimicrobial susceptibility profile of non-fermenting Gram-negative bacilli (NFGNB) isolated from clinical samples in a tertiary care hospital in Niger. Prospective, cross-sectional study. The study was carried out in a tertiary care hospital in Niger. All clinical samples received at the bacteriology laboratory during the study period for diagnostic purposes were included. Out of 548 clinical Gram-negative isolates, 60 strains of NFGNB (10.94%) were isolated. These NFGNB strains were mainly isolated from male patients (62%, n=37) with a mean age of 41.2±27.3 years. NFGNB was more frequent in urine samples (91.7%), followed by pus (6.6%). Among the NFGNB strains isolated, <i>Acinetobacter baumannii</i> was predominant (60%), followed by <i>Pseudomonas aeruginosa</i> (18.3%) and <i>Stenotrophomonas maltophilia</i> (13.33%). 20% (n=12) of NFGNB isolated were multidrug-resistant (MDR), including 13.33% (n=8) carbapenem-resistant <i>A. baumannii</i> and 6.67% (n=4) carbapenem-resistant <i>P. aeruginosa</i>. There is no statistically significant association between MDR-NFGNB and age, sex and origin of patients (p>0.05). Our study revealed a relatively high MDR-NFGNB prevalence rate in a Nigerien tertiary care hospital. These findings emphasise the need for vigilant antibiotic stewardship, with appropriate infection prevention and control practices to curb the emergence and spread of MDR-NFGNB infections in hospital settings.
Medical subject headings
- Gram-Negative Bacteria
- Gram-Negative Bacterial Infections
- Anti-Bacterial Agents
- Drug Resistance, Multiple, Bacterial
- Drug Resistance, Bacterial